A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Clinical trial NCT06794268 · RECRUITING
Trial details
- NCT number
- NCT06794268
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-04
- Primary completion
- 2044-08-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.